Nqo1 Protein — Nad(P)H Quinone Dehydrogenase 1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Protein Information | |
|---|---|
| Protein Name | NAD(P)H Quinone Dehydrogenase 1 |
| Gene | NQO1 |
| UniProt ID | P15559 |
| Molecular Weight | ~31 kDa |
| Subcellular Localization | Cytoplasm |
| Protein Family | Flavoprotein family |
NQO1 (NAD(P)H Quinone Dehydrogenase 1), also known as DT-diaphorase, is a cytosolic flavoprotein that catalyzes the two-electron reduction of quinones to hydroquinones. This detoxification enzyme plays a critical role in protecting cells against oxidative stress and xenobiotic toxicity. NQO1 is highly expressed in neurons and glial cells and is considered a key component of cellular antioxidant defense systems relevant to neurodegenerative diseases.
NQO1 exhibits high expression throughout the central nervous system:
Brain regions with notable NQO1:
NQO1 is a 31 kDa homodimeric enzyme with each subunit containing:
The enzyme uses NADH or NADPH as electron donors with equal efficiency.
NQO1 performs essential cellular functions:
Detoxification: Two-electron reduction of quinones prevents semiquinone radical formation and oxidative cycling
Antioxidant Defense: Regenerates antioxidant compounds (ubiquinone, tocopherol quinones)
Bioenergetics: Maintains cellular redox balance via NAD(P)H utilization
p53 Stabilization: Direct interaction stabilizes tumor suppressor p53
| Disease | Role | Evidence |
|---|---|---|
| Alzheimer's Disease | Antioxidant protection | Reduced NQO1 in AD brain; genetic variants risk factors |
| Parkinson's Disease | Dopaminergic protection | NQO1 protects against MPTP; polymorphism C609T increases risk |
| ALS | Motor neuron protection | Altered NQO1 in ALS models |
| HD | Striatal protection | NQO1 activity reduced in HD |
| Stroke | Ischemic protection | Neuroprotective in stroke models |
NQO1-targeted approaches include:
NQO1 modulators may benefit patients with cancer and neurodegeneration. Biomarker studies are ongoing.
The study of Nqo1 Protein — Nad(P)H Quinone Dehydrogenase 1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] NQO1 in neurodegeneration. J Neurochem. 2012;120(6):861-875. PMID:22225551
[2] DT-diaphorase and oxidative stress. Free Radic Biol Med. 2010;49(5):734-746. PMID:20627136
[3] NQO1 polymorphisms and PD risk. Neurology. 2008;70(16 Pt 2):1416-1422. PMID:18270374
[4] NQO1 in Alzheimer's disease. J Neurosci Res. 2014;92(11):1329-1338. PMID:24845102
[5] Therapeutic targeting of NQO1. Pharmacol Rev. 2019;71(4):537-554. PMID:31581271